Location of Repository

A high activity index of stearoyl-CoA desaturase is associated with increased risk of fracture in men

By H. Melhus, U. Risérus, E. Warensjö, L. Wernroth, K. Jensevik, L. Berglund, B. Vessby and K. Michaëlsson
Topics: Original Article
Publisher: Springer-Verlag
OAI identifier: oai:pubmedcentral.nih.gov:2440922
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (2004). Analysis of the contribution to type 2 diabetes susceptibility of sequence variation in the gene encoding stearoyl-CoA desaturase, a key regulator of lipid and carbohydrate metabolism.
    2. (2002). Assessment of dietary and genetic factors influencing serum and adipose fatty acid composition in obese female identical twins.
    3. (2004). Bone mineral density and markers of bone turnover in patients with glycogen storage disease types I, III and IX.
    4. (2003). Bone mineral density in children, adolescents and adults with glycogen storage disease type Ia: a crosssectional and longitudinal study.
    5. (1995). Bone mineralisation in type 1 glycogen storage disease.
    6. (1999). De novo lipogenesis in humans: metabolic and regulatory aspects.
    7. (2006). Dietary saturated fat intake is inversely associated with bone density in humans: analysis of NHANES III.
    8. (2001). Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later. Circulation 103:836– 934 Osteoporos Int
    9. (1983). Effects of dietary fatty acids and calcium levels on performance and mineral metabolism of broiler chickens.
    10. (1984). Effects of dietary saturated or unsaturated fatty acids and calcium levels on performance and mineral metabolism of broiler chicks.
    11. (2006). Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women. Nutr Metab Cardiovasc Dis 16:128–136
    12. (2005). Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men.
    13. (2005). Increased bone adiposity and peroxisomal proliferatoractivated receptor-gamma2 expression in type I diabetic mice.
    14. (2002). Increased lipogenesis and resistance of lipoproteins to oxidative modification in two patients with glycogen storage disease type 1a.
    15. (2002). Leptin regulates bone formation via the sympathetic nervous system.
    16. (2005). Leptin regulation of bone resorption by the sympathetic nervous system and CART.
    17. (1997). Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients.
    18. (1995). Long-term fat intake and biomarkers.
    19. (2002). Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity.
    20. (2002). Low bone mass in glycogen storage disease type 1 is associated with reduced muscle force and poor metabolic control.
    21. (2005). Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies.
    22. (2005). Plasma palmitoleic acid content and obesity in children.
    23. (1985). Platelet fatty acid composition in relation to fatty acid composition in plasma and to serum lipoprotein lipids in healthy subjects with special reference to the linoleic acid pathway. Clin Sci (Lond)
    24. (2004). PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors.
    25. (2004). PPARs and LXRs: atherosclerosis goes nuclear. Trends Endocrinol Metab
    26. (2005). Relationship between osteoporosis and cardiovascular disease in postmenopausal women.
    27. (2002). Relationship between stearoyl-CoA desaturase Osteoporos Int
    28. (2004). Role of fatty acid composition in the development of metabolic disorders in sucrose-induced obese rats. Exp Biol Med
    29. (2005). Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation.
    30. (2005). Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma.
    31. (2004). Serum leptin level is a regulator of bone mass.
    32. (2003). Serum retinol levels and the risk of fracture.
    33. (2005). Smoking and the risk of fracture in older men.
    34. (1996). The serum cholesterol ester fatty acid composition but not the serum concentration of alpha tocopherol predicts the development of myocardial infarction in 50-year-old men: 19 years follow-up.
    35. (2006). Thiazolidinedione use and bone loss in older diabetic adults.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.